Hidradenoma papilliferum: A clinicopathologic study of 264 tumors from 261 patients, with emphasis on mammary-type alterations

A.M. Konstantinova, M. Michal, D. Kacerovska, Dominic Spagnolo, C.J. Stewart, H. Kutzner, B. Zelger, J.A. Plaza, N. Denisjuk, V. Hejda, K. Shelekhova, M. Bisceglia, D. Danis, M. Zamecnik, K. Kerl, E. Guenova, D.V. Kazakov

    Research output: Contribution to journalArticlepeer-review

    26 Citations (Scopus)

    Abstract

    © 2016 Wolters Kluwer Health, Inc.Hidradenoma papilliferum (HP), also known as papillary hidradenoma, is the most common benign lesion of the female anogenital area derived from anogenital mammary-like glands (AGMLG). HP can be viewed conceptually as the cutaneous counterpart of mammary intraductal papilloma. The authors have studied 264 cases of HP, detailing various changes in the tumor and adjacent AGMLG, with emphasis on mammary-type alterations. In many HP, the authors noticed changes typical for benign breast lesions, such as sclerosing adenosis-like changes, usual, and atypical ductal hyperplasia. Almost in a third of cases, remnants of AGMLG adjacent to the lesion were evident, manifesting columnar changes reminiscent of those seen in breast lesions. This study shows that the histopathological changes in HP run a broad spectrum comparable with that in the mammary counterpart and benign breast disease.
    Original languageEnglish
    Pages (from-to)598-607
    Number of pages10
    JournalAmerican Journal of Dermatopathology
    Volume38
    Issue number8
    DOIs
    Publication statusPublished - 1 Aug 2016

    Fingerprint

    Dive into the research topics of 'Hidradenoma papilliferum: A clinicopathologic study of 264 tumors from 261 patients, with emphasis on mammary-type alterations'. Together they form a unique fingerprint.

    Cite this